Unbound MEDLINE

Procoagulant activities in human alveolar macrophages. European journal of respiratory diseases. [Eur J Respir Dis] Journal article

 
TitleProcoagulant activities in human alveolar macrophages.
Author(s)Nakstad B, Boye NP, Lyberg T 
InstitutionDepartment of Pathology, Ullevaal Hospital, Oslo, Norway.
SourceEur J Respir Dis 1987 Nov; 71(5):459-71.
MeSHAdult
Blood Coagulation
Blood Coagulation Factors
Bronchoalveolar Lavage Fluid
Female
Humans
In Vitro
Lymphocytes
Macrophages
Male
Monocytes
Pulmonary Alveoli
Research Support, Non-U.S. Gov't
Thromboplastin
AbstractThe coexistence of fibrin and tissue macrophages is a common finding in the histopathology of chronic lung inflammatory diseases. Human lung alveolar macrophages (LAM) obtained by lavage of healthy donors can initiate the coagulation sequence by expressing procoagulant factors. The procoagulants of LAM were in this study identified to be either thromboplastin (tissue factor) or a direct factor X activator, probably a thromboplastin/factor VII complex. LAM did not show inducible thromboplastin synthesis as did monocytes when stimulated in vitro. LAM were separated into four subpopulations by density gradient centrifugation. The specific thromboplastin activity of subpopulation cells varied inversely with their density. Low-density subpopulations of LAM released microvesicles from their surface which could be recovered in the culture medium, and which expressed procoagulant activities with the same characteristics as the LAM procoagulants. These findings suggest that alveolar macrophages and the membrane vesicles shed from their surface contribute to local fibrin deposition in the lungs by expressing procoagulant factors.
Languageeng
Pub Type(s)Journal Article
PubMed ID3443166
  
Advertise on this site.